Total Payments
$87,380
2024 Payments
$1,540
Companies
10
Transactions
42
Payment Breakdown by Category
Consulting$70,210 (80.3%)
Other$14,746 (16.9%)
Travel$1,059 (1.2%)
Food & Beverage$980.97 (1.1%)
Education$384.93 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,210 | 7 | 80.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,596 | 2 | 14.4% |
| Grant | $2,150 | 1 | 2.5% |
| Travel and Lodging | $1,059 | 4 | 1.2% |
| Food and Beverage | $980.97 | 14 | 1.1% |
| Education | $384.93 | 14 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $50,700 | 3 | $0 (2023) |
| Ipsen Innovation | $26,065 | 6 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $6,188 | 22 | $0 (2020) |
| Arteriocyte Medical Systems, Inc. | $2,336 | 1 | $0 (2018) |
| LEO Pharma AS | $1,540 | 1 | $0 (2024) |
| TherapeuticsMD, Inc. | $260.01 | 2 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $221.72 | 3 | $0 (2017) |
| MILLICENT US INC | $25.83 | 2 | $0 (2020) |
| Duchesnay USA Incorporated | $23.38 | 1 | $0 (2019) |
| SCYNEXIS, Inc. | $20.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,540 | 1 | LEO Pharma AS ($1,540) |
| 2023 | $18,200 | 2 | Incyte Corporation ($18,200) |
| 2022 | $32,520 | 2 | Incyte Corporation ($32,500) |
| 2020 | $10,619 | 6 | Ipsen Innovation ($10,456) |
| 2019 | $279.87 | 9 | TherapeuticsMD, Inc. ($122.62) |
| 2018 | $20,340 | 11 | Ipsen Innovation ($15,609) |
| 2017 | $3,882 | 11 | AMAG Pharmaceuticals, Inc. ($3,660) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | LEO Pharma AS | — | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| 12/12/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $9,100.00 | General |
| 01/30/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $9,100.00 | General |
| 08/22/2022 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $32,500.00 | General |
| 07/28/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 03/07/2020 | TherapeuticsMD, Inc. | — | Food and Beverage | In-kind items and services | $137.39 | General |
| 02/25/2020 | Ipsen Innovation | DYSPORT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,260.00 | General |
| Category: Neurology | ||||||
| 02/25/2020 | Ipsen Innovation | DYSPORT (Drug) | Travel and Lodging | In-kind items and services | $110.18 | General |
| Category: Neurology | ||||||
| 02/25/2020 | Ipsen Innovation | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $86.00 | General |
| Category: Neurology | ||||||
| 01/14/2020 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), VYLEESI | Education | In-kind items and services | $13.05 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/12/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), VYLEESI | Education | In-kind items and services | $18.70 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/24/2019 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 09/27/2019 | TherapeuticsMD, Inc. | — | Food and Beverage | In-kind items and services | $122.62 | General |
| 09/26/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $18.32 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/24/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $46.15 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/04/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $13.40 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/04/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $0.33 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 04/17/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $23.23 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/27/2019 | Duchesnay USA Incorporated | Osphena (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Women's Health | ||||||
| 11/16/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $124.61 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/30/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $13.13 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 07/04/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $7.05 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 05/02/2018 | Ipsen Innovation | Dysport (Drug) | Consulting Fee | Cash or cash equivalent | $5,470.00 | General |
| Category: Neurology | ||||||
| 03/20/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Grant | Cash or cash equivalent | $2,150.00 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
About Dr. Andrew Goldstein, M.D
Dr. Andrew Goldstein, M.D is a Gynecology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811041411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Goldstein, M.D has received a total of $87,380 in payments from pharmaceutical and medical device companies, with $1,540 received in 2024. These payments were reported across 42 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($70,210).
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Gynecology, Gynecology
- Location Washington, DC
- Active Since 01/22/2007
- Last Updated 07/08/2007
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811041411
Products in Payments
- Dysport (Drug) $15,609
- DYSPORT (Drug) $10,456
- INTRAROSA (Drug) $6,116
- ADDYI (Drug) $221.72
- MAKENA (Drug) $72.19
- Femring (Drug) $25.83
- Osphena (Drug) $23.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Washington
Dr. Gaby Moawad, Md, MD
Gynecology — Payments: $1.2M
Gynecology $1.2M
Dr. Anthony Scialli, Md, MD
Gynecology — Payments: $215,415
Gynecology $215,415
Dr. Marilyn Jerome, M.d, M.D
Gynecology — Payments: $14,055
Gynecology $14,055
Dr. Cheryl Iglesia, Md, MD
Gynecology — Payments: $10,045
Gynecology $10,045
Maria Vargas, Md, MD
Gynecology — Payments: $4,271
Gynecology $4,271
Dr. George Samman, M.d, M.D
Gynecology — Payments: $2,439
Gynecology $2,439